GleamWall
中文EN

WRBY Warby Parker Inc.

Ophthalmic Goods · NYSE · SEC CIK 1504776 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.9%
TTM net income YoY942.0%
TTM EPS YoY216,172,782,113,783,936.0%
Revenue 3-yr CAGR12.6%
Net income 3-yr CAGR—

Margins

Gross margin54.7%
Operating margin0.2%
Net margin0.8%
FCF margin2.3%
EBITDA margin6.1%

Returns

ROE1.9%
ROA1.0%
ROIC (approx.)1.1%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets49.1%
Debt / equity0.00x
Current ratio2.26x
Interest coverage—

Cash quality & payout

Operating cash flow / net income13.67x
Accruals ratio-12.6%
Payout ratio—
Capex / revenue8.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$244.74M$235.51M$242.45M$211.97M$221.68M$214.47M$223.78M$190.64M
Cost of revenue$111.56M$99.05M$111.41M$100.92M$101.73M$100.87M$97.80M$87.52M
Gross profit$133.17M$136.46M$131.04M$111.04M$119.94M$113.61M$125.98M$103.13M
SG&A expense$129.61M$133.29M$129.37M$117.89M$116.38M$118.13M$123.51M$112.54M
Operating income$3.56M$3.17M$1.67M-$6.85M$3.57M-$4.53M$2.47M-$9.42M
Pretax income$6.17M$5.25M$4.00M-$5.09M$5.75M-$2.54M$4.93M-$6.78M
Income tax$563,000$607,000$821,000$862,000-$125,000-$789,000$1.45M$93,000
Net income$5.60M$4.64M$3.18M-$5.95M$5.87M-$1.75M$3.47M-$6.88M
EBITDA$17.99M$17.24M$15.44M$6.25M$16.10M$7.96M$14.63M$2.92M
EPS (basic)0.040.040.03—0.05-0.010.03—
EPS (diluted)0.040.040.03—0.05-0.010.03—
Weighted avg. shares (diluted)126.15M125.75M125.55M—125.41M122.56M124.63M—
Balance sheet
Cash & equivalents$287.91M$292.67M$288.25M$286.36M$280.36M$286.38M$265.07M$254.16M
Receivables$2.13M$2.08M$1.76M$3.29M$1.14M$1.14M$1.47M$1.95M
Inventory$46.29M$42.10M$46.45M$44.51M$45.59M$43.27M$48.61M$52.34M
Current assets$366.13M$370.84M$357.69M$352.44M$344.06M$346.10M$330.60M$326.05M
PP&E, net$212.10M$201.81M$191.32M$187.45M$182.58M$177.16M$173.79M$170.46M
Total assets$792.15M$772.32M$736.41M$720.92M$706.92M$701.90M$682.75M$676.49M
Current liabilities$162.23M$163.48M$153.28M$150.13M$132.06M$135.53M$122.61M$130.35M
Total liabilities$388.80M$380.33M$360.60M$353.19M$337.30M$340.45M$328.67M$336.42M
Shareholders' equity$403.35M$391.99M$375.81M$367.73M$369.62M$361.45M$354.09M$340.07M
Cash flow statement
Operating cash flow$24.72M$29.62M$24.51M$23.25M$17.97M$40.20M$29.36M$19.91M
Capital expenditure$26.70M$22.86M$16.14M$15.12M$19.49M$16.29M$16.15M$17.72M
Free cash flow-$1.98M$6.75M$8.37M$8.13M-$1.52M$23.91M$13.21M$2.19M
Investing cash flow-$26.70M-$22.86M-$16.14M-$15.12M-$19.49M-$16.29M-$16.15M-$17.72M
Financing cash flow-$2.83M-$2.30M-$6.16M-$2.31M-$4.61M-$2.77M-$2.30M$1.21M
Depreciation & amortization$14.43M$14.07M$13.77M$13.10M$12.53M$12.49M$12.16M$12.33M
Stock-based compensation$8.55M$9.90M$11.39M$6.28M$7.03M$8.90M$12.33M$8.63M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.